SCHEMBL25272575

SCHEMBL25272575

CN(CCN1CCN(c2ccc(C(=O)O)cn2)CC1)C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 6/20 0.45
▸ PPARA Q07869 6/20 0.45
▸ OGA O60502 1/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMO Q99835 1/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.40
▸ PPARD Q03181 3/20 0.39
▸ HTR1A P08908 3/20 0.39
▸ DRD2 P14416 2/20 0.39
▸ HTR2A P28223 2/20 0.39
▸ DRD4 P21917 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ TMEM97 Q5BJF2 1/20 0.39
▸ SIGMAR1 Q99720 1/20 0.39
▸ ACACB O00763 1/20 0.38
▸ ACACA Q13085 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31570895 1.00 PPARG (0.45) PPARGPPARAOGAKMT2ANPC1
SCHEMBL30404916 0.88 P2RY12 (0.50) PPARGPPARAOGAKMT2ANPC1
SCHEMBL25228640 0.84 HRH3 (0.46) KMT2AHRH3HTR1ADRD2HTR2A
SCHEMBL22644656 0.82 GPR119 (0.47) PPARAHRH3DRD2DRD4DRD3
SCHEMBL4274914 0.77 SMO (0.50) PPARGPPARAOGAKMT2ANPC1
SCHEMBL63484 0.76 CKS1B (0.58) KMT2ANPC1RAB9AHRH3CRBN
SCHEMBL31491303 0.76 HRH3 (0.39) HRH3DRD4
SCHEMBL24735573 0.76 HRH3 (0.52) PPARGPPARAKMT2ANPC1RAB9A
SCHEMBL9381722 0.76 HRH3 (0.56) PPARGPPARAOGAKMT2ANPC1
SCHEMBL21521500 0.75 TIPARP (0.60) HRH3DRD2HTR7DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444717-A1 BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS University of Florida Research Foundation, Incorporated (US) 2024-10-16 — — EP disclosed
WO-2023107606-A1 BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-06-15 — — WO disclosed
WO-2023107606-A1 BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-06-15 — — WO disclosed
Send feedback